Hepatitis Monthly

Published by: Kowsar

Oxidative Stress Response in Patients Infected by Diverse Hepatitis C Virus Genotypes

Mohammad Hassan Khadem Ansari 1 , Mir-Davood Omrani 2 and Fatemeh Kheradmand 3 , *
Authors Information
1 Clinical Biochemistry Department, Faculty of Medicine, Urmia University of Medical Sciences, Urmia, IR Iran
2 Medical Genetics Department, Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
3 Cellular and Molecular Research Center, Clinical Biochemistry Department, Faculty of Medicine, Urmia University of Medical Sciences, Urmia, IR Iran
Article information
  • Hepatitis Monthly: February 28, 2015, 15 (2); e22069
  • Published Online: February 21, 2015
  • Article Type: Research Article
  • Received: July 15, 2014
  • Revised: October 12, 2014
  • Accepted: February 1, 2015
  • DOI: 10.5812/hepatmon.22069

To Cite: Khadem Ansari M H, Omrani M, Kheradmand F. Oxidative Stress Response in Patients Infected by Diverse Hepatitis C Virus Genotypes, Hepat Mon. 2015 ; 15(2):e22069. doi: 10.5812/hepatmon.22069.

Copyright © 2015, Kowsar Corp. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
  • 1. Shepard CW, Finelli L, Alter MJ. Global epidemiology of hepatitis C virus infection. Lancet Infect Dis. 2005; 5(9): 558-67[PubMed]
  • 2. Simula MP, De Re V. Hepatitis C virus-induced oxidative stress and mitochondrial dysfunction: a focus on recent advances in proteomics. Proteomics Clin Appl. 2010; 4(10-11): 782-93[PubMed]
  • 3. Brown RS. Hepatitis C and liver transplantation. Nature. 2005; 436(7053): 973-8[PubMed]
  • 4. Charlton M. Recurrence of hepatitis C infection: Where are we now? Liver Transpl. 2005; (11 Suppl 2)-62[PubMed]
  • 5. Choi J, Ou JH. Mechanisms of liver injury. III. Oxidative stress in the pathogenesis of hepatitis C virus. Am J Physiol Gastrointest Liver Physiol. 2006; 290(5)-51[PubMed]
  • 6. Vidali M, Tripodi MF, Ivaldi A, Zampino R, Occhino G, Restivo L, et al. Interplay between oxidative stress and hepatic steatosis in the progression of chronic hepatitis C. J Hepatol. 2008; 48(3): 399-406[PubMed]
  • 7. Nakatani SM, Santos CA, Riediger IN, Krieger MA, Duarte CA, do Carmo Debur M, et al. Comparative performance evaluation of hepatitis C virus genotyping based on the 5' untranslated region versus partial sequencing of the NS5B region of brazilian patients with chronic hepatitis C. Virol J. 2011; 8(1): 459[PubMed]
  • 8. Bullock GC, Bruns DE, Haverstick DM. Hepatitis C genotype determination by melting curve analysis with a single set of fluorescence resonance energy transfer probes. Clin Chem. 2002; 48(12): 2147-54[PubMed]
  • 9. Omrani MD, Khadem Ansari MH. Hepatitis C Virus Genotyping by Melting Curve Analysis in West Azerbaijan, Northwest of Iran. Hepatitis Monthly. 2009; 9(2): 133-6
  • 10. Bowden DS, Berzsenyi MD. Chronic hepatitis C virus infection: genotyping and its clinical role. Future Microbiol. 2006; 1(1): 103-12[PubMed]
  • 11. Strahotin CS, Babich M. Hepatitis C variability, patterns of resistance, and impact on therapy. Adv Virol. 2012: 267483[PubMed]
  • 12. Gryadunov D, Nicot F, Dubois M, Mikhailovich V, Zasedatelev A, Izopet J. Hepatitis C virus genotyping using an oligonucleotide microarray based on the NS5B sequence. J Clin Microbiol. 2010; 48(11): 3910-7[PubMed]
  • 13. Buege JA, Aust SD. Microsomal lipid peroxidation. Methods Enzymol. 1978; 52: 302-10[PubMed]
  • 14. Gonzalez-Gallego J, Garcia-Mediavilla MV, Sanchez-Campos S. Hepatitis C virus, oxidative stress and steatosis: current status and perspectives. Curr Mol Med. 2011; 11(5): 373-90[PubMed]
  • 15. Madill J, Arendt B, Aghdassi E, Chow C, Guindi M, Therapondos G, et al. Oxidative stress and nutritional factors in hepatitis C virus-positive liver recipients, controls, and hepatitis C virus-positive nontransplant patients. Transplant Proc. 2010; 42(5): 1744-9[PubMed]
  • 16. Mahmood S, Kawanaka M, Kamei A, Izumi A, Nakata K, Niiyama G, et al. Immunohistochemical evaluation of oxidative stress markers in chronic hepatitis C. Antioxid Redox Signal. 2004; 6(1): 19-24[DOI][PubMed]
  • 17. Jahan S, Khaliq S, Ijaz B, Ahmad W, Hassan S. Role of HCV Core gene of genotype 1a and 3a and host gene Cox-2 in HCV-induced pathogenesis. Virol J. 2011; 8: 155[DOI][PubMed]
  • 18. Duygu F, Koruk ST, Karsen H, Aksoy N, Taskin A, Hamidanoglu M. Prolidase and oxidative stress in chronic hepatitis C. J Clin Lab Anal. 2012; 26(4): 232-7[DOI][PubMed]
  • 19. Venturini D, Simao AN, Barbosa DS, Lavado EL, Narciso VE, Dichi I, et al. Increased oxidative stress, decreased total antioxidant capacity, and iron overload in untreated patients with chronic hepatitis C. Dig Dis Sci. 2010; 55(4): 1120-7[DOI][PubMed]
  • 20. Abdalla MY, Ahmad IM, Spitz DR, Schmidt WN, Britigan BE. Hepatitis C virus-core and non structural proteins lead to different effects on cellular antioxidant defenses. J Med Virol. 2005; 76(4): 489-97[DOI][PubMed]
  • 21. Korenaga M, Wang T, Li Y, Showalter LA, Chan T, Sun J, et al. Hepatitis C virus core protein inhibits mitochondrial electron transport and increases reactive oxygen species (ROS) production. J Biol Chem. 2005; 280(45): 37481-8[DOI][PubMed]
  • 22. Cunningham-Rundles S, Ahrn S, Abuav-Nussbaum R, Dnistrian A. Development of immunocompetence: role of micronutrients and microorganisms. Nutr Rev. 2002; 60(5 Pt 2)-72[PubMed]
  • 23. Resti M, Jara P, Hierro L, Azzari C, Giacchino R, Zuin G, et al. Clinical features and progression of perinatally acquired hepatitis C virus infection. J Med Virol. 2003; 70(3): 373-7[DOI][PubMed]
  • 24. Pawlotsky JM. Mechanisms of antiviral treatment efficacy and failure in chronic hepatitis C. Antiviral Res. 2003; 59(1): 1-11[PubMed]
  • 25. Zeuzem S. Heterogeneous virologic response rates to interferon-based therapy in patients with chronic hepatitis C: who responds less well? Ann Intern Med. 2004; 140(5): 370-81[PubMed]
  • 26. Strahotin CS, Babich M. Hepatitis C variability, patterns of resistance, and impact on therapy. Adv Virol. 2012; : 267483[PubMed]
  • 27. Koike K, Moriya K. Metabolic aspects of hepatitis C viral infection: steatohepatitis resembling but distinct from NASH. J Gastroenterol. 2005; 40(4): 329-36[DOI][PubMed]
  • 28. Asselah T, Rubbia-Brandt L, Marcellin P, Negro F. Steatosis in chronic hepatitis C: why does it really matter? Gut. 2006; 55(1): 123-30[DOI][PubMed]
  • 29. Idrees M, Riazuddin S. Frequency distribution of hepatitis C virus genotypes in different geographical regions of Pakistan and their possible routes of transmission. BMC Infect Dis. 2008; 8: 69[DOI][PubMed]
  • 30. Amoroso P, Rapicetta M, Tosti ME, Mele A, Spada E, Buonocore S, et al. Correlation between virus genotype and chronicity rate in acute hepatitis C. J Hepatol. 1998; 28(6): 939-44[PubMed]
  • 31. Zein NN. Clinical significance of hepatitis C virus genotypes. Clin Microbiol Rev. 2000; 13(2): 223-35[PubMed]
  • 32. Hnatyszyn HJ. Chronic hepatitis C and genotyping: the clinical significance of determining HCV genotypes. Antivir Ther. 2005; 10(1): 1-11[PubMed]
  • 33. Melhem A, Stern M, Shibolet O, Israeli E, Ackerman Z, Pappo O, et al. Treatment of chronic hepatitis C virus infection via antioxidants: results of a phase I clinical trial. J Clin Gastroenterol. 2005; 39(8): 737-42[PubMed]
  • 34. Groenbaek K, Friis H, Hansen M, Ring-Larsen H, Krarup HB. The effect of antioxidant supplementation on hepatitis C viral load, transaminases and oxidative status: a randomized trial among chronic hepatitis C virus-infected patients. Eur J Gastroenterol Hepatol. 2006; 18(9): 985-9[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments